NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
10/28/2025
Back to search
Official data from USPTO
PARAMOUNT PEPTIDES
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
23
Latest update
10/28/2025
Trademark type
Combined
Nice classes
1, 5
Filing date
06/17/2024
Registration date
10/28/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/28/2025
Last transaction
10/28/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
11/22/2023
First use in commerce
11/22/2023
Drawing code
3
Owner type
16
Owner location
Irvine, CA
Examiner
BERNS,LEE ANNE
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of the words "PARAMOUNT PEPTIDES" in a stylized font below a stylized representation of a DNA double helix. The design features a continuous blue line forming the DNA helix. The DNA helix is blue outlined in black and the wording appears in bold black capitalized letters outlined in blue.
Holders and representatives
Holders
Paramount Peptides, LLC
Representatives
Kaveh Newmen Newmen Law, P.C.
Technical classification
Nice Classes
Class 1Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
High-purity peptides for industrialscientificlaboratory research purposes; chemical preparations for laboratory research use; peptide substrates for use in research and diagnostic testsother than for medical or veterinary purposes
Class 5
Diagnostic preparations for medical and veterinary purposes in the nature of peptide substrates; sanitary preparations for medical purposes; pharmaceutical preparationssynthetic peptides for the treatment of metabolic disordersweight management disorderscardiovascular diseases and cardiovascular risk factorstissue injurieswound healing disordersmusculoskeletal injuriesgastrointestinal disordersinflammatory conditionsneurological conditionstraumatic brain injurycognitive function disordersmuscle development disorderscellular energy metabolism disorders to be used in medical and veterinary research
Publications
History of USPTO decisions and trademark events.
23 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
10/28/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/09/2025
PUBO
PUBLISHED FOR OPPOSITION
09/09/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/03/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/11/2025
XAEC
EXAMINER'S AMENDMENT ENTERED
08/11/2025
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
08/11/2025
GNEA
EXAMINERS AMENDMENT E-MAILED
08/11/2025
CNEA
EXAMINERS AMENDMENT -WRITTEN
08/11/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/12/2025
GNRT
NON-FINAL ACTION E-MAILED
05/12/2025
CNRT
NON-FINAL ACTION WRITTEN
05/12/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/14/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/14/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/14/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/15/2025
GNRT
NON-FINAL ACTION E-MAILED
01/15/2025
CNRT
NON-FINAL ACTION WRITTEN
01/15/2025
DOCK
ASSIGNED TO EXAMINER
01/10/2025
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
01/09/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/09/2025
NWAP
NEW APPLICATION ENTERED
06/18/2024
Continuous trademark protection
Get notified about every new filing that threatens PARAMOUNT PEPTIDES or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.